17909356Weiss GJ, Vokes EE, Bunn PA, Magree L, Rusk J, Albert D, Kelly KJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerAntineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Lung NeoplasmsAdenocarcinoma; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Remission Induction; Sulindac; Survival Rate; Taxoids; Treatment OutcomeDocetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial. J Thorac Oncol. 2007 Oct; 2(10):933-8.J Thorac Oncol2007-10-01T00:00:002007Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000230Disorders29111600.582288AdenocarcinomaD000368Living Beings1341183530.29479AgedD000328Living Beings1578255770.254454AdultD002294Disorders19910750.588875Carcinoma, Squamous CellD000971Procedures30624340.47627Antineoplastic Combined Chemotherapy ProtocolsD002289Disorders15810730.519185Carcinoma, Non-Small-Cell LungD003131Procedures38816800.739615Combined Modality TherapyD004305Concepts & Ideas52019580.724117Dose-Response Relationship, DrugD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD009367Concepts & IdeasProcedures34719320.6701Neoplasm StagingD008175Disorders32822600.404557Lung NeoplasmsD005260Physiology1992444050.191184FemaleD006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleD016896Concepts & Ideas101179490.402421Treatment OutcomeD018287Disorders21390.970051Carcinoma, Large CellD011379Procedures74536690.561484PrognosisD011879Concepts & Ideas1024680.894038Radiotherapy DosageD043823Chemicals & Drugs561290.941532TaxoidsD015996Concepts & Ideas45518560.724919Survival RateD012074Procedures1657220.853042Remission InductionD013467Chemicals & Drugs8100.99373SulindacD020714Concepts & Ideas902700.919887Maximum Tolerated DoseMedicineUniversity of ChicagoEverett E.VokesEverett E. Vokes41.78927490000000-87.601250000000001920Vokes, Everett E.Professortrue1ProfessorProfessorAuthorship 5709720.07969970.07969971authors10.2523has subject area